Citigroup’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.28K | Sell |
|
|||||
|
2025
Q1 | $57.9K | Buy |
|
|||||
|
2024
Q4 | $61.2K | Buy |
|
|||||
|
2024
Q3 | $99.8K | Buy |
|
|||||
|
2024
Q2 | $36K | Buy |
|
|||||
|
2024
Q1 | $38.3K | Buy |
|
|||||
|
2023
Q4 | $26K | Sell |
|
|||||
|
2023
Q3 | $157K | Sell |
|
|||||
|
2023
Q2 | $224K | Sell |
|
|||||
|
2023
Q1 | $694K | Sell |
|
|||||
|
2022
Q4 | $558K | Buy |
|
|||||
|
2022
Q3 | $154K | Buy |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $14K | Sell |
|
|||||
|
2021
Q4 | $87K | Sell |
|
|||||
|
2021
Q3 | $347K | Buy |
|
|||||
|
2021
Q2 | $33K | Buy |
|
|||||
|
2021
Q1 | $19K | Buy |
|
|||||
|
2020
Q4 | $10K | Hold |
|
|||||
|
2020
Q3 | $6K | Hold |
|
|||||
|
2020
Q2 | $5K | Sell |
|
|||||
|
2020
Q1 | $31K | Buy |
|
|||||
|
2019
Q4 | $30K | Buy |
|
|||||
|
2019
Q3 | $15K | Sell |
|
|||||
|
2019
Q2 | $35K | Sell |
|
|||||
|
2019
Q1 | $45K | Buy |
|
|||||
|
2018
Q4 | $26K | Sell |
|
|||||
|
2018
Q3 | $68K | Buy |
|
|||||
|
2018
Q2 | $59K | Buy |
|
|||||
|
2018
Q1 | $71K | Buy |
|
|||||
|
2017
Q4 | $30K | Buy |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2017
Q2 | $3K | Sell |
|
|||||
|
2017
Q1 | $9K | Sell |
|
|||||
|
2016
Q4 | $257K | Buy |
|
|||||
|
2016
Q3 | $27K | Sell |
|
|||||
|
2016
Q2 | $22K | Sell |
|
|||||
|
2016
Q1 | $138K | Buy |
|
|||||
|
2015
Q4 | $70K | Buy |
|
|||||
|
2015
Q3 | $1K | Sell |
|
|||||
|
2015
Q2 | $3K | Sell |
|
|||||
|
2015
Q1 | $17K | Sell |
|
|||||
|
2014
Q4 | $39K | Buy |
|
|||||
|
2014
Q3 | $9K | Buy |
|
|||||
|
2014
Q2 | $2K | Sell |
|
|||||
|
2014
Q1 | $19K | Sell |
|
|||||
|
2013
Q4 | $64K | Buy |
|
|||||
|
2013
Q3 | $1K | Sell |
|
|||||
|
2013
Q2 | $2K | Buy |
|